Cell Damage in Light Chain Amyloidosis: FIBRIL INTERNALIZATION, TOXICITY AND CELL-MEDIATED SEEDING
Overview
Authors
Affiliations
Light chain (AL) amyloidosis is an incurable human disease characterized by the misfolding, aggregation, and systemic deposition of amyloid composed of immunoglobulin light chains (LC). This work describes our studies on potential mechanisms of AL cytotoxicity. We have studied the internalization of AL soluble proteins and amyloid fibrils into human AC16 cardiomyocytes by using real time live cell image analysis. Our results show how external amyloid aggregates rapidly surround the cells and act as a recruitment point for soluble protein, triggering the amyloid fibril elongation. Soluble protein and external aggregates are internalized into AC16 cells via macropinocytosis. AL amyloid fibrils are shown to be highly cytotoxic at low concentrations. Additionally, caspase assays revealed soluble protein induces apoptosis, demonstrating different cytotoxic mechanisms between soluble protein and amyloid aggregates. This study emphasizes the complex immunoglobulin light chain-cell interactions that result in fibril internalization, protein recruitment, and cytotoxicity that may occur in AL amyloidosis.
Whole tissue proteomic analyses of cardiac ATTR and AL unveil mechanisms of tissue damage.
Netzel B, Charlesworth M, Johnson K, French A, Dispenzieri A, Maleszewski J Amyloid. 2025; 32(1):72-80.
PMID: 39773246 PMC: 11825277. DOI: 10.1080/13506129.2024.2448440.
Sheehan K, Jeon H, Corr S, Hayes J, Mok K Protein J. 2024; 44(1):1-20.
PMID: 39527351 DOI: 10.1007/s10930-024-10237-6.
The myocardial function index (MFI): An integrated measure of cardiac function in AL-cardiomyopathy.
Akhiyat N, Anand V, Kumar V, Ryu A, Gibbons R, Borlaug B Int J Cardiol Heart Vasc. 2024; 55:101525.
PMID: 39483149 PMC: 11525457. DOI: 10.1016/j.ijcha.2024.101525.
Cardiac Amyloidosis: State-of-the-Art Review in Molecular Pathology.
Salzillo C, Franco R, Ronchi A, Quaranta A, Marzullo A Curr Issues Mol Biol. 2024; 46(10):11519-11536.
PMID: 39451564 PMC: 11506355. DOI: 10.3390/cimb46100684.
Arrhythmias and Device Therapies in Cardiac Amyloidosis.
Bukhari S, Khan S, Ghoweba M, Khan B, Bashir Z J Clin Med. 2024; 13(5).
PMID: 38592132 PMC: 10932014. DOI: 10.3390/jcm13051300.